Search results for: Lotte Steuten
Filter search results
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?. OHE Consulting Report. Available from https://www.ohe.org/publications/health-technology-assessment-gene-therapies-are-our-methods-fit-purpose. Brassel, S. and Steuten, L. (2020a) The Broader Value of Vaccines: The Return…
Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?
17 September 2020
…gained or the health opportunity costs of vaccination programs that were previously shown cost-effective to the NHS. Brassel, S., Neri, M., O’Neill, P. and Steuten, L., 2020. Realising the Value…
NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?
1 May 2024
…that access to NHS resources was unequal across regions (the “postcode lottery” ), and an increasing number of medical breakthroughs and the challenge of their adoption. Enablers (factors that allowed…
OHE Achievements in 2018
27 December 2018
…from Adrian Towse, who becomes Director Emeritus and Senior Research Fellow, as well as Olga Rozanova and Charlotte Davies. We are sorry to lose OHE’s Deputy Director and Head of…
Let’s talk about (health) inequalities
1 April 2022
…1, we could think of interventions related to access to services, and education around (and exposure to) lifestyle risk factors. For instance, health inequalities arising by the ‘ postcode lottery’…
Trade Mark Legislation and the Pharmaceutical Industry
1 May 1999
…differences may be the determining factor in consumer choice. In the absence of trade marks, however, consumer choice is a lottery, since the consumer cannot identify the product with the…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…culture, and exampled their BeWell policy, which strives to improve wellbeing and foster multistakeholder partnerships to reskill and upskill the workforce. Charlotte Frost (Schroders) shared that they have also adopted…
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…& Steuten L., 2023. Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism. OHE Contract Research. Available from https://www.ohe.org/publications/incentivising-new-antibiotics-designing-value-based-delinked-pull-incentive-antbiotics/ CCA (Council of Canadian Academies). (2023). Overcoming Resistance. Ottawa (ON): Expert…
The BRAVE Initiative: The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement
1 September 2020
…these gaps. Please note, this report has been superseded by the following journal publication: Bell, E., Neri, M., & Steuten, L. (2021). Towards a Broader Assessment of Value in Vaccines:…